iHuman
9 hedge funds and large institutions have $254K invested in iHuman in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
29% more funds holding
Funds holding: 7 → 9 (+2)
0.03% more ownership
Funds ownership: 0.51% → 0.54% (+0.03%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
24% less capital invested
Capital invested by funds: $333K → $254K (-$78.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.3K |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
+$26.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$12.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$495 |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$265 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$49.8K |
| 2 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$302 |
| 3 |
BlackRock
New York
|
-$209 |
IH Hedge Fund Activity: Q4 2025 in Review
9 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2025, worth a combined $254K — down 24% from $333K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IH positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $27.3K. The largest seller was Morgan Stanley, cutting an estimated $49.8K.
- 9 institutional investors held iHuman (IH) as of Q4 2025, up from 7 in Q3 2025.
- Funds reported $254K of iHuman stock for Q4 2025, down 24% quarter-over-quarter.
- 2 funds opened new iHuman positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest iHuman buyer in Q4 2025 was Susquehanna International Group, an estimated $27.3K added.
- The largest iHuman seller in Q4 2025 was Morgan Stanley, an estimated $49.8K sold.
Based on aggregated 13F filings for Q4 2025.